Skip to content

Clinical trials

Phase 3 Gastroesophageal Reflux trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 3 Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20043
20055
20068
20072
20087
20094
20122
20171
20182
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Wyeth is now a wholly owned subsidiary of Pfizer7
Eisai Inc.6
AstraZeneca5
Ironwood Pharmaceuticals, Inc.2
Novartis2
Associated Scientists to Help Minimize Allergies1
Aviel Roy-Shapira, M.D.1
Braintree Laboratories1
Cogentus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux40
Heartburn8
Asthma2
Disease2
Dyspepsia2
Esophagitis2
Acute Coronary Syndrome1
Cerebrovascular Disorders1
Coronary Artery Disease1
Coronary Thrombosis1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.